Michigan Medicine and Blue Cross Blue Shield of Michigan have reached a tentative agreement that allows continued in-network care at Michigan Medicine while terms are finalized in the coming weeks.

Negotiations aim to preserve patient access and affordability, with a renewal date set for late June and the final terms to be disclosed once agreed.

The deal seeks to prevent patients from seeking care outside the state and to avoid disruptions to access to specialized services at Michigan Medicine.

This brief update functions as a concise business/healthcare policy item rather than an in-depth feature or opinion piece.

The information is based on a Michigan Medicine press release and prior reporting.

No specific financial terms or exact effective dates are provided in the available excerpt.

The agreement addresses concerns about out-of-network rates and the burden of finding alternative providers, highlighting protection for patients needing specialized care.

The update follows prior coverage about the dispute and its potential impact on patient access and premiums in Michigan's healthcare landscape.

Patients covered by BCBSM and Michigan Medicine express relief that their existing providers will remain available, noting trouble finding comparable replacements.

Without a contract, hundreds of thousands of BCBSM members and their employers faced higher costs or provider churn, underscoring the stakes of the negotiation.

Michigan Medicine contends it has been under-compensated for high-cost care and research, with reimbursements lower than comparable Big Ten academic medical programs.

Historical context notes warnings that plan withdrawals could occur if a deal was not reached by the June renewal, framing the urgency of the agreement.